At a glance
ClinicalIndex Comparison RecordN/ACompleted· 102 enrolled
Drug / intervention
Cannabisdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
EMPOWER Study: Exploring Medically Perceived Benefits, Use and Interest in Psychedelics and Cannabinoids: Observational Study With First Responders and Military Personnel Examining Previous Use Experience and Interest in Participating in Future Research Studies
In Brief
An observational study evaluating Cannabis for PTSD and 7 related conditions. Completed, enrolled 102 participants across 1 site.
Detailed Summary
The primary objective of this study is to collect insights from first responders and military personnel on their need for, use of, and interest in physical and/or mental health medical marijuana or psychedelic-assisted therapy programs. These preliminary data will help to inform and guide the development of a larger patient-oriented study and the design of a clinical program geared towards enhancing therapy treatments for first responders and military personnel.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPTSD, Anxiety, Anxiety Disorders, Depression, Depressive Disorder, Psychological, Psychedelic Experiences, Psychedelic Drug Dependence
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedJul 2021
Primary CompletionFeb 2022
Study CompletionFeb 2022
TodayJul 2026
First PostedJul 16, 2021
Enrollment StartJun 4, 2021
Primary CompletionFeb 4, 2022
Study CompletionFeb 15, 2022
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 5.0 years ago
Interventions
Cannabisdrug
Recreational Cannabis